Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Pliant Therapeutics announces FDA clearance of IND application for PLN-101095 » 08:12
02/02/23
02/02
08:12
02/02/23
08:12
PLRX

Pliant Therapeutics

$34.44 /

-0.61 (-1.74%)

Pliant Therapeutics…

Pliant Therapeutics announced that the U.S. Food and Drug Administration, FDA, has cleared the company's Investigational New Drug, IND, application for PLN-101095, an oral, small molecule, dual selective inhibitor of integrins alphavbeta8 and alphavbeta1. A Phase 1 first-in-human study evaluating PLN-101095 in patients with solid tumors that are resistant to immune checkpoint inhibitors, ICIs, is expected to initiate in the second quarter of 2023. "PLN-101095 represents our third program to advance into clinical development, this time targeting significant unmet need of cancer patients with a suboptimal response to immune checkpoint inhibitors," said Eric Lefebvre, M.D., Chief Medical Officer at Pliant Therapeutics. "Based on the compelling preclinical activity seen in tumor models with PLN-101095 in combination with immune checkpoint inhibitors, we look forward to evaluating this combination in patients with solid tumors."

ShowHide Related Items >><<
PLRX Pliant Therapeutics
$34.44 /

-0.61 (-1.74%)

PLRX Pliant Therapeutics
$34.44 /

-0.61 (-1.74%)

01/24/23 SVB Securities
Pliant Therapeutics price target raised to $45 from $33 at SVB Securities
01/24/23 Citi
Pliant Therapeutics price target raised to $55 from $36 at Citi
01/23/23 JPMorgan
Pliant Therapeutics price target raised to $51 from $42 at JPMorgan
01/23/23 Cantor Fitzgerald
Pliant Therapeutics price target raised to $52 from $40 at Cantor Fitzgerald
PLRX Pliant Therapeutics
$34.44 /

-0.61 (-1.74%)

  • 25
    Jan
  • 13
    Jul
PLRX Pliant Therapeutics
$34.44 /

-0.61 (-1.74%)

Over a week ago
Hot Stocks
Pliant Therapeutics appoints Cheung as Chief Human Resources Officer » 08:09
01/25/23
01/25
08:09
01/25/23
08:09
PLRX

Pliant Therapeutics

$33.00 /

+2.64 (+8.70%)

Pliant Therapeutics…

Pliant Therapeutics announced Lily Cheung as its Chief Human Resources Officer. Cheung brings over 25 years of Human Resources experience across the technology and biopharmaceutical industries, including more than 15 years of commercial-stage experience. Cheung joins Pliant from Synthekine, a privately held biotechnology company.

ShowHide Related Items >><<
PLRX Pliant Therapeutics
$33.00 /

+2.64 (+8.70%)

PLRX Pliant Therapeutics
$33.00 /

+2.64 (+8.70%)

01/24/23 SVB Securities
Pliant Therapeutics price target raised to $45 from $33 at SVB Securities
01/24/23 Citi
Pliant Therapeutics price target raised to $55 from $36 at Citi
01/23/23 JPMorgan
Pliant Therapeutics price target raised to $51 from $42 at JPMorgan
01/23/23 Cantor Fitzgerald
Pliant Therapeutics price target raised to $52 from $40 at Cantor Fitzgerald
PLRX Pliant Therapeutics
$33.00 /

+2.64 (+8.70%)

  • 25
    Jan
  • 13
    Jul
PLRX Pliant Therapeutics
$33.00 /

+2.64 (+8.70%)

Syndicate
Pliant Therapeutics 8.33M share Secondary priced at $30.00 » 21:24
01/24/23
01/24
21:24
01/24/23
21:24
PLRX

Pliant Therapeutics

$33.00 /

+2.64 (+8.70%)

The deal size was…

The deal size was increased to $250M from $175M and priced below last closing price of $32.94. JPMorgan and Piper Sandler are acting as joint book running managers for the offering.

ShowHide Related Items >><<
PLRX Pliant Therapeutics
$33.00 /

+2.64 (+8.70%)

PLRX Pliant Therapeutics
$33.00 /

+2.64 (+8.70%)

01/24/23 SVB Securities
Pliant Therapeutics price target raised to $45 from $33 at SVB Securities
01/24/23 Citi
Pliant Therapeutics price target raised to $55 from $36 at Citi
01/23/23 JPMorgan
Pliant Therapeutics price target raised to $51 from $42 at JPMorgan
01/23/23 Cantor Fitzgerald
Pliant Therapeutics price target raised to $52 from $40 at Cantor Fitzgerald
PLRX Pliant Therapeutics
$33.00 /

+2.64 (+8.70%)

  • 25
    Jan
  • 13
    Jul
PLRX Pliant Therapeutics
$33.00 /

+2.64 (+8.70%)

Recommendations
Pliant Therapeutics price target raised to $45 from $33 at SVB Securities » 07:14
01/24/23
01/24
07:14
01/24/23
07:14
PLRX

Pliant Therapeutics

$30.24 /

+7.585 (+33.48%)

SVB Securities analyst…

SVB Securities analyst Thomas Smith raised the firm's price target on Pliant Therapeutics to $45 from $33 to reflect better-than-expected 320mg dose cohort results of bexotegrast in the Phase 2a INTEGRIS-IPF study that reinforce confidence that bexo will compete for a best-in-class profile in IPF. The firm has an Outperform rating on the shares.

ShowHide Related Items >><<
PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

01/24/23 Citi
Pliant Therapeutics price target raised to $55 from $36 at Citi
01/23/23 JPMorgan
Pliant Therapeutics price target raised to $51 from $42 at JPMorgan
01/23/23 Cantor Fitzgerald
Pliant Therapeutics price target raised to $52 from $40 at Cantor Fitzgerald
12/13/22 Stifel
Pliant Therapeutics initiated with a Buy at Stifel
PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

  • 25
    Jan
  • 13
    Jul
PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

Recommendations
Pliant Therapeutics price target raised to $55 from $36 at Citi » 06:22
01/24/23
01/24
06:22
01/24/23
06:22
PLRX

Pliant Therapeutics

$30.24 /

+7.585 (+33.48%)

Citi analyst David…

Citi analyst David Lebowitz raised the firm's price target on Pliant Therapeutics to $55 from $36 and keeps a Buy rating on the shares. The company released interim results from 320mg bexotegrast cohort in Phase IIa trial in idiopathic pulmonary fibrosis showing promising safety and efficacy as an add-on therapy to standard of care, the analyst tells investors in a research note. The firm updated the model to reflect bexotegrast's higher probability of success.

ShowHide Related Items >><<
PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

01/23/23 JPMorgan
Pliant Therapeutics price target raised to $51 from $42 at JPMorgan
01/23/23 Cantor Fitzgerald
Pliant Therapeutics price target raised to $52 from $40 at Cantor Fitzgerald
12/13/22 Stifel
Pliant Therapeutics initiated with a Buy at Stifel
12/07/22 JPMorgan
Pliant Therapeutics initiated with an Overweight at JPMorgan
PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

  • 25
    Jan
  • 13
    Jul
PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

On The Fly
Fly Intel: After-Hours Movers » 17:51
01/23/23
01/23
17:51
01/23/23
17:51
BBCP

Concrete Pumping

$6.53 /

+0.01 (+0.15%)

, AXLA

Axcella Health

/

+

, HPK

HighPeak Energy

$26.89 /

+0.855 (+3.28%)

, PLRX

Pliant Therapeutics

$30.24 /

+7.585 (+33.48%)

, IPAR

Inter Parfums

$113.83 /

+2.315 (+2.08%)

, CR

Crane

$110.17 /

+1.89 (+1.75%)

, ZION

Zions Bancorp

$52.67 /

+1.21 (+2.35%)

, IBTX

Independent Bank

$61.43 /

+0.66 (+1.09%)

, EFSC

Enterprise Financial

$48.96 /

+0.47 (+0.97%)

Check out this evening's…

ShowHide Related Items >><<
ZION Zions Bancorp
$52.67 /

+1.21 (+2.35%)

PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

IPAR Inter Parfums
$113.83 /

+2.315 (+2.08%)

IBTX Independent Bank
$61.43 /

+0.66 (+1.09%)

HPK HighPeak Energy
$26.89 /

+0.855 (+3.28%)

CR Crane
$110.17 /

+1.89 (+1.75%)

BBCP Concrete Pumping
$6.53 /

+0.01 (+0.15%)

AXLA Axcella Health
/

+

BBCP Concrete Pumping
$6.53 /

+0.01 (+0.15%)

AXLA Axcella Health
/

+

12/15/22 SVB Securities
Axcella Health downgraded to Market Perform from Outperform at SVB Securities
12/15/22 H.C. Wainwright
H.C. Wainwright downgrades Axcella with discontinuation 'major detriment'
12/15/22 H.C. Wainwright
Axcella Health downgraded to Neutral from Buy at H.C. Wainwright
11/02/22 Chardan
Axcella Health price target lowered to $5 from $7 at Chardan
HPK HighPeak Energy
$26.89 /

+0.855 (+3.28%)

04/28/22 Roth MKM
HighPeak Energy price target raised to $38.75 from $32.50 at Roth Capital
PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

01/23/23 JPMorgan
Pliant Therapeutics price target raised to $51 from $42 at JPMorgan
01/23/23 Cantor Fitzgerald
Pliant Therapeutics price target raised to $52 from $40 at Cantor Fitzgerald
12/13/22 Stifel
Pliant Therapeutics initiated with a Buy at Stifel
12/07/22 JPMorgan
Pliant Therapeutics initiated with an Overweight at JPMorgan
IPAR Inter Parfums
$113.83 /

+2.315 (+2.08%)

01/06/23 DA Davidson
Inter Parfums price target raised to $126 from $116 at DA Davidson
01/03/23 Piper Sandler
Inter Parfums price target raised to $115 from $108 at Piper Sandler
12/23/22 DA Davidson
Inter Parfums price target raised to $116 from $104 at DA Davidson
11/22/22 DA Davidson
Inter Parfums price target raised to $104 from $98 at DA Davidson
CR Crane
$110.17 /

+1.89 (+1.75%)

12/12/22 Morgan Stanley
Crane upgraded to Overweight from Equal Weight at Morgan Stanley
10/11/22 Stifel
Crane price target lowered to $121 from $123 at Stifel
04/18/22 Stifel
Crane price target lowered to $134 from $137 at Stifel
ZION Zions Bancorp
$52.67 /

+1.21 (+2.35%)

01/03/23 Barclays
Zions Bancorp downgraded to Underweight from Equal Weight at Barclays
12/21/22 DA Davidson
DA Davidson upgrades Zions Bancorp to Buy on low valuation
12/20/22 DA Davidson
Zions Bancorp upgraded to Buy from Neutral at DA Davidson
12/13/22 JPMorgan
Zions Bancorp price target lowered to $49 from $55 at JPMorgan
IBTX Independent Bank
$61.43 /

+0.66 (+1.09%)

12/09/22 Truist
Independent Bank price target lowered to $70 from $74 at Truist
10/26/22 Truist
Independent Bank price target lowered to $74 from $80 at Truist
10/26/22 Hovde Group
Independent Bank downgraded to Market Perform from Outperform at Hovde Group
09/16/22 Piper Sandler
Independent Bank price target lowered to $75 from $78 at Piper Sandler
EFSC Enterprise Financial
$48.96 /

+0.47 (+0.97%)

10/26/22 DA Davidson
Enterprise Financial upgraded to Buy from Neutral at DA Davidson
03/21/22 Boenning & Scattergood
Enterprise Financial initiated with an Outperform at Boenning & Scattergood
ZION Zions Bancorp
$52.67 /

+1.21 (+2.35%)

PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

IPAR Inter Parfums
$113.83 /

+2.315 (+2.08%)

IBTX Independent Bank
$61.43 /

+0.66 (+1.09%)

HPK HighPeak Energy
$26.89 /

+0.855 (+3.28%)

EFSC Enterprise Financial
$48.96 /

+0.47 (+0.97%)

CR Crane
$110.17 /

+1.89 (+1.75%)

BBCP Concrete Pumping
$6.53 /

+0.01 (+0.15%)

AXLA Axcella Health
/

+

  • 25
    Jan
  • 13
    Jul
ZION Zions Bancorp
$52.67 /

+1.21 (+2.35%)

PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

IPAR Inter Parfums
$113.83 /

+2.315 (+2.08%)

CR Crane
$110.17 /

+1.89 (+1.75%)

AXLA Axcella Health
/

+

On The Fly
What You Missed On Wall Street On Monday » 16:22
01/23/23
01/23
16:22
01/23/23
16:22
XYL

Xylem

$101.37 /

-8.73 (-7.93%)

, AQUA

Evoqua Water

$47.29 /

+6.245 (+15.22%)

, CRM

Salesforce

$155.89 /

+4.71 (+3.12%)

, SPOT

Spotify

$99.90 /

+1.95 (+1.99%)

, BKR

Baker Hughes

$30.58 /

-0.485 (-1.56%)

, SYF

Synchrony

$34.56 /

-0.84 (-2.37%)

, W

Wayfair

$59.37 /

+12.645 (+27.06%)

, AMD

AMD

$76.54 /

+6.5 (+9.28%)

, QCOM

Qualcomm

$131.01 /

+8.07 (+6.56%)

, ZM

Zoom Video

$70.94 /

+1.46 (+2.10%)

, SHOP

Shopify

$44.05 /

+3.58 (+8.85%)

, TPR

Tapestry

$44.21 /

+0.5 (+1.14%)

, WFC

Wells Fargo

$45.02 /

+1.1 (+2.50%)

, BAC

Bank of America

$34.33 /

+0.475 (+1.40%)

, JPM

JPMorgan

$137.27 /

+2.2 (+1.63%)

, PYPL

PayPal

$79.49 /

+0.4 (+0.51%)

, WDC

Western Digital

$41.78 /

+3.35 (+8.72%)

, F

Ford

$12.81 /

+0.405 (+3.26%)

, AAPL

Apple

$141.11 /

+3.3 (+2.39%)

, DLB

Dolby

$79.14 /

+1.02 (+1.31%)

, DIS

Disney

$105.70 /

+2.25 (+2.17%)

, PLRX

Pliant Therapeutics

$30.24 /

+7.585 (+33.48%)

, LCID

Lucid Group

$8.81 /

+0.995 (+12.74%)

, CPRX

Catalyst Pharmaceuticals

$14.76 /

-6.03 (-29.01%)

, AGEN

Agenus

$2.55 /

-0.145 (-5.38%)

, AMT

American Tower

$215.66 /

-5.81 (-2.62%)

, PEBK

Peoples Bancorp

$33.01 /

+0.38 (+1.16%)

, CZR

Caesars

$50.36 /

+2.84 (+5.98%)

, BMRC

Bank of Marin

$30.92 /

-0.655 (-2.07%)

, NWBI

Northwest Bancshares

$13.58 /

-0.23 (-1.67%)

, BOH

Bank of Hawaii

$75.11 /

-3.09 (-3.95%)

, SUMO

Sumo Logic

$9.88 /

+2.19 (+28.50%)

Get caught up quickly on…

ShowHide Related Items >><<
ZM Zoom Video
$70.94 /

+1.46 (+2.10%)

XYL Xylem
$101.37 /

-8.73 (-7.93%)

WFC Wells Fargo
$45.02 /

+1.1 (+2.50%)

WDC Western Digital
$41.78 /

+3.35 (+8.72%)

W Wayfair
$59.37 /

+12.645 (+27.06%)

TPR Tapestry
$44.21 /

+0.5 (+1.14%)

SYF Synchrony
$34.56 /

-0.84 (-2.37%)

SUMO Sumo Logic
$9.88 /

+2.19 (+28.50%)

SPOT Spotify
$99.90 /

+1.95 (+1.99%)

SHOP Shopify
$44.05 /

+3.58 (+8.85%)

QCOM Qualcomm
$131.01 /

+8.07 (+6.56%)

PYPL PayPal
$79.49 /

+0.4 (+0.51%)

PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

PEBK Peoples Bancorp
$33.01 /

+0.38 (+1.16%)

NWBI Northwest Bancshares
$13.58 /

-0.23 (-1.67%)

LCID Lucid Group
$8.81 /

+0.995 (+12.74%)

JPM JPMorgan
$137.27 /

+2.2 (+1.63%)

F Ford
$12.81 /

+0.405 (+3.26%)

DIS Disney
$105.70 /

+2.25 (+2.17%)

CZR Caesars
$50.36 /

+2.84 (+5.98%)

CRM Salesforce
$155.89 /

+4.71 (+3.12%)

CPRX Catalyst Pharmaceuticals
$14.76 /

-6.03 (-29.01%)

BOH Bank of Hawaii
$75.11 /

-3.09 (-3.95%)

BKR Baker Hughes
$30.58 /

-0.485 (-1.56%)

BAC Bank of America
$34.33 /

+0.475 (+1.40%)

AQUA Evoqua Water
$47.29 /

+6.245 (+15.22%)

AMT American Tower
$215.66 /

-5.81 (-2.62%)

AMD AMD
$76.54 /

+6.5 (+9.28%)

AGEN Agenus
$2.55 /

-0.145 (-5.38%)

AAPL Apple
$141.11 /

+3.3 (+2.39%)

XYL Xylem
$101.37 /

-8.73 (-7.93%)

01/24/23 Morgan Stanley
Xylem-Evoqua deal timing a surprise, but not tie-up, says Morgan Stanley
01/24/23 Loop Capital
Xylem deal for Evoqua priced 'high' but 'great' long-term fit, says Loop Capital
01/24/23 Stifel
Xylem upgraded to Buy from Hold at Stifel
01/23/23 Stifel
Xylem stock reaction to Evoqua deal 'confounding,' says Stifel
AQUA Evoqua Water
$47.29 /

+6.245 (+15.22%)

CRM Salesforce
$155.89 /

+4.71 (+3.12%)

01/23/23 Deutsche Bank
Salesforce price target lowered to $190 from $200 at Deutsche Bank
01/20/23 Cowen
Salesforce downgraded to Market Perform at Cowen with disruption risk elevated
01/20/23 Cowen
Salesforce downgraded to Market Perform from Outperform at Cowen
01/17/23 DA Davidson
Salesforce initiated with a Neutral at DA Davidson
SPOT Spotify
$99.90 /

+1.95 (+1.99%)

01/23/23 Piper Sandler
Spotify workforce reduction to be viewed positively, says Piper Sandler
01/17/23 Truist
Truist sees expectations for Spotify subs and active users as 'reasonable'
01/12/23 Jefferies
Spotify downgraded to Hold from Buy at Jefferies
01/05/23 UBS
Spotify price target lowered to $100 from $142 at UBS
BKR Baker Hughes
$30.58 /

-0.485 (-1.56%)

01/24/23 Evercore ISI
Baker Hughes price target raised to $37 from $33 at Evercore ISI
01/24/23 Susquehanna
Baker Hughes price target raised to $40 from $35 at Susquehanna
01/19/23 Benchmark
Baker Hughes initiated with a Buy at Benchmark
11/18/22 Piper Sandler
Baker Hughes price target raised to $34 from $30 at Piper Sandler
SYF Synchrony
$34.56 /

-0.84 (-2.37%)

01/24/23 BMO Capital
Synchrony price target lowered to $53 from $56 at BMO Capital
01/24/23 JMP Securities
Synchrony price target raised to $42 from $39 at JMP Securities
01/24/23 Citi
Synchrony price target raised to $45 from $44 at Citi
01/10/23 JPMorgan
Synchrony price target lowered to $36 from $39 at JPMorgan
W Wayfair
$59.37 /

+12.645 (+27.06%)

01/23/23 Wedbush
Wayfair upgraded to Outperform from Neutral at Wedbush
01/23/23 BofA
BofA double upgrades Wayfair to Buy on 'significant improvement'
01/23/23 BofA
Wayfair upgraded to Buy from Underperform at BofA
01/23/23 Oppenheimer
Wayfair price target lowered to $70 from $110 at Oppenheimer
AMD AMD
$76.54 /

+6.5 (+9.28%)

01/24/23 Cowen
AMD remains in a very strong competitive position, says Cowen
01/24/23 Bernstein
AMD downgraded to Market Perform from Outperform at Bernstein
01/23/23 Truist
AMD price target raised to $79 from $70 at Truist
01/23/23 Barclays
AMD upgraded to Overweight from Equal Weight at Barclays
QCOM Qualcomm
$131.01 /

+8.07 (+6.56%)

01/23/23 Barclays
Qualcomm upgraded to Overweight from Equal Weight at Barclays
01/18/23 Citi
Citi opens 'negative catalyst watch' on Intel and Qualcomm
01/11/23 KeyBanc
KeyBanc says iPhone survey shows supply partial recovery, some shortages remain
01/10/23 Piper Sandler
Piper Sandler sees no strategic reason for Apple to insource Wi-Fi combo chip
ZM Zoom Video
$70.94 /

+1.46 (+2.10%)

01/23/23 MKM Partners
MKM Partners cuts Zoom Video to Neutral, sees limited upside in Meetings growth
01/23/23 MKM Partners
Zoom Video downgraded to Neutral from Buy at MKM Partners
01/17/23 Piper Sandler
Zoom Video price target lowered to $75 from $77 at Piper Sandler
12/15/22 Wedbush
Wedbush initiates Zoom Video with a Neutral and $80 price target
SHOP Shopify
$44.05 /

+3.58 (+8.85%)

01/23/23 Deutsche Bank
Shopify upgraded to Buy from Hold at Deutsche Bank
01/19/23 Truist
Shopify price target raised to $41 from $35 at Truist
01/18/23 DA Davidson
Shopify assumed with a Neutral at DA Davidson
01/17/23 Loop Capital
Shopify price target raised to $39 from $36 at Loop Capital
TPR Tapestry
$44.21 /

+0.5 (+1.14%)

01/23/23 Barclays
Capri Holdings price target raised to $72 from $56 at Barclays
01/23/23 Barclays
Tapestry downgraded to Equal Weight from Overweight at Barclays
12/20/22 Raymond James
Tapestry initiated with an Outperform at Raymond James
12/19/22 Raymond James
Tapestry initiated with an Outperform at Raymond James
WFC Wells Fargo
$45.02 /

+1.1 (+2.50%)

01/24/23 BofA
Banks' potential new online wallet unlikely to threaten PayPal, says BofA
01/17/23 Citi
Wells Fargo price target raised to $52 from $48 at Citi
01/17/23 Piper Sandler
Wells Fargo downgraded to Neutral from Overweight at Piper Sandler
01/17/23 Jefferies
Wells Fargo downgraded to Hold from Buy at Jefferies
BAC Bank of America
$34.33 /

+0.475 (+1.40%)

01/17/23 Citi
Bank of America price target raised to $38 from $36 at Citi
01/17/23 Piper Sandler
Bank of America downgraded to Underweight from Neutral at Piper Sandler
01/10/23 Odeon Capital
Bank of America upgraded to Buy from Hold at Odeon Capital
JPM JPMorgan
$137.27 /

+2.2 (+1.63%)

01/17/23 Citi
JPMorgan price target raised to $165 from $150 at Citi
01/17/23 Piper Sandler
JPMorgan price target raised to $157 from $150 at Piper Sandler
01/06/23 Deutsche Bank
JPMorgan downgraded to Hold with $145 target at Deutsche Bank
PYPL PayPal
$79.49 /

+0.4 (+0.51%)

01/23/23 Bernstein
PayPal's 2023 earnings appear largely de-risked, says Bernstein
01/18/23 Jefferies
PayPal price target lowered to $85 from $90 at Jefferies
01/18/23 SMBC Nikko
PayPal downgraded to Underperform from Neutral at SMBC Nikko
WDC Western Digital
$41.78 /

+3.35 (+8.72%)

01/23/23 Exane BNP Paribas
Western Digital upgraded to Neutral from Underperform at Exane BNP Paribas
01/06/23 Benchmark
Western Digital upgraded to Hold at Benchmark after Kioxia merger talks report
01/06/23 Benchmark
Western Digital upgraded to Hold from Sell at Benchmark
01/05/23 Deutsche Bank
Western Digital, Kioxia deal makes 'a lot of sense,' says Deutsche Bank
F Ford
$12.81 /

+0.405 (+3.26%)

01/11/23 Goldman Sachs
Goldman continues to prefer Tesla and GM among automakers
12/21/22 Morgan Stanley
Tesla shedding $600B of value presents buying opportunity, says Morgan Stanley
12/05/22 Jefferies
Fox Factory price target raised to $135 from $120 at Jefferies
12/05/22 Jefferies
Polaris price target raised to $106 from $100 at Jefferies
AAPL Apple
$141.11 /

+3.3 (+2.39%)

01/24/23 Bernstein
Demand for Apple iPhones should decline in 2023, says Bernstein
01/23/23 UBS
Apple's iPhone softness offset by improving currency factors, says UBS
01/23/23 Deutsche Bank
Apple price target lowered to $160 from $170 at Deutsche Bank
01/19/23 JPMorgan
Apple facing 'tough setup' for upcoming earnings, says JPMorgan
DLB Dolby
$79.14 /

+1.02 (+1.31%)

11/18/22 Barrington
Dolby downgraded to Market Perform from Outperform at Barrington
10/14/22 Tigress Financial
Dolby price target lowered to $116 from $128 at Tigress Financial
06/08/22
Baird to hold a conference
DIS Disney
$105.70 /

+2.25 (+2.17%)

01/24/23 Wells Fargo
Wells Fargo bullish on Disney, says Iger 'will come out swinging'
01/17/23 Huber Research
Disney initiated with an Overweight at Huber Research
01/17/23 Truist
Truist names Disney Top Idea for 2023, price target lowered to $120 from $125
01/17/23 Wells Fargo
ESPN/ABC potential spin would make sense, add value, says Wells Fargo
PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

01/24/23 SVB Securities
Pliant Therapeutics price target raised to $45 from $33 at SVB Securities
01/24/23 Citi
Pliant Therapeutics price target raised to $55 from $36 at Citi
01/23/23 JPMorgan
Pliant Therapeutics price target raised to $51 from $42 at JPMorgan
01/23/23 Cantor Fitzgerald
Pliant Therapeutics price target raised to $52 from $40 at Cantor Fitzgerald
LCID Lucid Group
$8.81 /

+0.995 (+12.74%)

01/22/23 Citi
Lucid Group resumed with a Buy at Citi
01/12/23 Cantor Fitzgerald
Lucid's Q4 production pre-announcement 'encouraging, says Cantor Fitzgerald
01/12/23 Evercore ISI
Evercore ISI says Lucid FY/Q4 production serves as glimmer of execution progress
12/15/22 BofA
Lucid Group resumed with a Buy at BofA
CPRX Catalyst Pharmaceuticals
$14.76 /

-6.03 (-29.01%)

01/23/23 Piper Sandler
ANDA filing for generic Firdapse not a surprise, says Piper Sandler
01/19/23 Truist
Catalyst Pharmaceuticals price target raised to $22 from $18 at Truist
12/21/22 H.C. Wainwright
Catalyst Pharmaceuticals price target raised to $24 from $18 at H.C. Wainwright
12/19/22 Piper Sandler
Catalyst Pharmaceuticals price target raised to $20 from $18 at Piper Sandler
AGEN Agenus
$2.55 /

-0.145 (-5.38%)

12/08/22 EF Hutton
Agenus initiated with a Buy at EF Hutton
09/27/22 SMBC Nikko
Agenus initiated with an Outperform at SMBC Nikko
03/03/22 B. Riley
Agenus price target lowered to $8 from $11 at B. Riley
03/02/22 H.C. Wainwright
Agenus price target raised to $14 from $12 at H.C. Wainwright
AMT American Tower
$215.66 /

-5.81 (-2.62%)

01/23/23 KeyBanc
American Tower downgraded to Sector Weight from Overweight at KeyBanc
01/22/23 Citi
American Tower buyout of Cellnex a possibility, says Citi
01/13/23 Truist
American Tower price target lowered to $275 from $325 at Truist
01/12/23 Deutsche Bank
American Tower upgraded to Buy from Hold at Deutsche Bank
PEBK Peoples Bancorp
$33.01 /

+0.38 (+1.16%)

CZR Caesars
$50.36 /

+2.84 (+5.98%)

01/24/23 Stifel
Stifel ups Caesars price target, says time for investors to revisit
01/24/23 Barclays
Caesars price target raised to $66 from $65 at Barclays
01/04/23 BofA
Caesars price target lowered to $50 from $55 at BofA
12/14/22 BofA
Caesars downgraded to Neutral at BofA with growth momentum levelling out
BMRC Bank of Marin
$30.92 /

-0.655 (-2.07%)

NWBI Northwest Bancshares
$13.58 /

-0.23 (-1.67%)

09/29/22 Janney Montgomery Scott
Janney starts Northwest Bancshares with a Neutral, sees $15 fair value
09/29/22 Janney Montgomery Scott
Northwest Bancshares initiated with a Neutral at Janney Montgomery Scott
07/11/22 B. Riley
Northwest Bancshares price target lowered to $11 from $14 at B. Riley
05/06/22 Piper Sandler
Northwest Bancshares downgraded to Underweight from Neutral at Piper Sandler
BOH Bank of Hawaii
$75.11 /

-3.09 (-3.95%)

01/23/23 Keefe Bruyette
Keefe keeps Market Perform on Bank of Hawaii, says margin likely under pressure
10/25/22 DA Davidson
Bank of Hawaii price target lowered to $76 from $80 at DA Davidson
07/11/22 Jefferies
Bank of Hawaii price target lowered to $79 from $87 at Jefferies
SUMO Sumo Logic
$9.88 /

+2.19 (+28.50%)

01/24/23 William Blair
Sumo Logic takeout could be double share price, says William Blair
01/24/23 Jefferies
Sumo Logic price target raised to $11 from $8.50 at Jefferies
12/12/22 RBC Capital
Coupa Software upgraded to Sector Perform from Underperform at RBC Capital
07/13/22 Piper Sandler
Sumo Logic price target lowered to $8 from $10 at Piper Sandler
ZM Zoom Video
$70.94 /

+1.46 (+2.10%)

XYL Xylem
$101.37 /

-8.73 (-7.93%)

WFC Wells Fargo
$45.02 /

+1.1 (+2.50%)

WDC Western Digital
$41.78 /

+3.35 (+8.72%)

W Wayfair
$59.37 /

+12.645 (+27.06%)

TPR Tapestry
$44.21 /

+0.5 (+1.14%)

SYF Synchrony
$34.56 /

-0.84 (-2.37%)

SUMO Sumo Logic
$9.88 /

+2.19 (+28.50%)

SPOT Spotify
$99.90 /

+1.95 (+1.99%)

SHOP Shopify
$44.05 /

+3.58 (+8.85%)

QCOM Qualcomm
$131.01 /

+8.07 (+6.56%)

PYPL PayPal
$79.49 /

+0.4 (+0.51%)

PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

PEBK Peoples Bancorp
$33.01 /

+0.38 (+1.16%)

NWBI Northwest Bancshares
$13.58 /

-0.23 (-1.67%)

LCID Lucid Group
$8.81 /

+0.995 (+12.74%)

JPM JPMorgan
$137.27 /

+2.2 (+1.63%)

F Ford
$12.81 /

+0.405 (+3.26%)

DLB Dolby
$79.14 /

+1.02 (+1.31%)

DIS Disney
$105.70 /

+2.25 (+2.17%)

CZR Caesars
$50.36 /

+2.84 (+5.98%)

CRM Salesforce
$155.89 /

+4.71 (+3.12%)

CPRX Catalyst Pharmaceuticals
$14.76 /

-6.03 (-29.01%)

BOH Bank of Hawaii
$75.11 /

-3.09 (-3.95%)

BMRC Bank of Marin
$30.92 /

-0.655 (-2.07%)

BKR Baker Hughes
$30.58 /

-0.485 (-1.56%)

BAC Bank of America
$34.33 /

+0.475 (+1.40%)

AQUA Evoqua Water
$47.29 /

+6.245 (+15.22%)

AMT American Tower
$215.66 /

-5.81 (-2.62%)

AMD AMD
$76.54 /

+6.5 (+9.28%)

AGEN Agenus
$2.55 /

-0.145 (-5.38%)

AAPL Apple
$141.11 /

+3.3 (+2.39%)

  • 25
    Jan
  • 13
    Jul
  • 03
    Jun
ZM Zoom Video
$70.94 /

+1.46 (+2.10%)

WFC Wells Fargo
$45.02 /

+1.1 (+2.50%)

WDC Western Digital
$41.78 /

+3.35 (+8.72%)

W Wayfair
$59.37 /

+12.645 (+27.06%)

TPR Tapestry
$44.21 /

+0.5 (+1.14%)

SYF Synchrony
$34.56 /

-0.84 (-2.37%)

SUMO Sumo Logic
$9.88 /

+2.19 (+28.50%)

SPOT Spotify
$99.90 /

+1.95 (+1.99%)

SHOP Shopify
$44.05 /

+3.58 (+8.85%)

QCOM Qualcomm
$131.01 /

+8.07 (+6.56%)

PYPL PayPal
$79.49 /

+0.4 (+0.51%)

LCID Lucid Group
$8.81 /

+0.995 (+12.74%)

JPM JPMorgan
$137.27 /

+2.2 (+1.63%)

F Ford
$12.81 /

+0.405 (+3.26%)

DLB Dolby
$79.14 /

+1.02 (+1.31%)

DIS Disney
$105.70 /

+2.25 (+2.17%)

CZR Caesars
$50.36 /

+2.84 (+5.98%)

CRM Salesforce
$155.89 /

+4.71 (+3.12%)

BKR Baker Hughes
$30.58 /

-0.485 (-1.56%)

BAC Bank of America
$34.33 /

+0.475 (+1.40%)

AMT American Tower
$215.66 /

-5.81 (-2.62%)

AMD AMD
$76.54 /

+6.5 (+9.28%)

AAPL Apple
$141.11 /

+3.3 (+2.39%)

ZM Zoom Video
$70.94 /

+1.46 (+2.10%)

XYL Xylem
$101.37 /

-8.73 (-7.93%)

WFC Wells Fargo
$45.02 /

+1.1 (+2.50%)

WDC Western Digital
$41.78 /

+3.35 (+8.72%)

W Wayfair
$59.37 /

+12.645 (+27.06%)

TPR Tapestry
$44.21 /

+0.5 (+1.14%)

SYF Synchrony
$34.56 /

-0.84 (-2.37%)

SUMO Sumo Logic
$9.88 /

+2.19 (+28.50%)

SPOT Spotify
$99.90 /

+1.95 (+1.99%)

SHOP Shopify
$44.05 /

+3.58 (+8.85%)

QCOM Qualcomm
$131.01 /

+8.07 (+6.56%)

PYPL PayPal
$79.49 /

+0.4 (+0.51%)

PLRX Pliant Therapeutics
$30.24 /

+7.585 (+33.48%)

NWBI Northwest Bancshares
$13.58 /

-0.23 (-1.67%)

F Ford
$12.81 /

+0.405 (+3.26%)

DLB Dolby
$79.14 /

+1.02 (+1.31%)

DIS Disney
$105.70 /

+2.25 (+2.17%)

CZR Caesars
$50.36 /

+2.84 (+5.98%)

CRM Salesforce
$155.89 /

+4.71 (+3.12%)

CPRX Catalyst Pharmaceuticals
$14.76 /

-6.03 (-29.01%)

BMRC Bank of Marin
$30.92 /

-0.655 (-2.07%)

BKR Baker Hughes
$30.58 /

-0.485 (-1.56%)

BAC Bank of America
$34.33 /

+0.475 (+1.40%)

AQUA Evoqua Water
$47.29 /

+6.245 (+15.22%)

AMT American Tower
$215.66 /

-5.81 (-2.62%)

AMD AMD
$76.54 /

+6.5 (+9.28%)

AGEN Agenus
$2.55 /

-0.145 (-5.38%)

AAPL Apple
$141.11 /

+3.3 (+2.39%)

ZM Zoom Video
$70.94 /

+1.46 (+2.10%)

XYL Xylem
$101.37 /

-8.73 (-7.93%)

WFC Wells Fargo
$45.02 /

+1.1 (+2.50%)

WDC Western Digital
$41.78 /

+3.35 (+8.72%)

W Wayfair
$59.37 /

+12.645 (+27.06%)

TPR Tapestry
$44.21 /

+0.5 (+1.14%)

SYF Synchrony
$34.56 /

-0.84 (-2.37%)

SPOT Spotify
$99.90 /

+1.95 (+1.99%)

SHOP Shopify
$44.05 /

+3.58 (+8.85%)

QCOM Qualcomm
$131.01 /

+8.07 (+6.56%)

PYPL PayPal
$79.49 /

+0.4 (+0.51%)

LCID Lucid Group
$8.81 /

+0.995 (+12.74%)

JPM JPMorgan
$137.27 /

+2.2 (+1.63%)

F Ford
$12.81 /

+0.405 (+3.26%)

DIS Disney
$105.70 /

+2.25 (+2.17%)

CZR Caesars
$50.36 /

+2.84 (+5.98%)

CRM Salesforce
$155.89 /

+4.71 (+3.12%)

BKR Baker Hughes
$30.58 /

-0.485 (-1.56%)

BAC Bank of America
$34.33 /

+0.475 (+1.40%)

AMD AMD
$76.54 /

+6.5 (+9.28%)

AAPL Apple
$141.11 /

+3.3 (+2.39%)

Syndicate
Pliant Therapeutics announces $175M common stock offering » 16:03
01/23/23
01/23
16:03
01/23/23
16:03
PLRX

Pliant Therapeutics

$30.18 /

+7.525 (+33.22%)

Pliant Therapeutics…

Pliant Therapeutics announced that it has commenced an underwritten public offering of $175M of its common stock. Pliant intends to use the net proceeds from the proposed offering, together with its existing cash, cash equivalents and short-term investments, to develop its ongoing and future preclinical and clinical programs including bexotegrast and PLN-101095, further develop its integrin targeting platform, to fund working capital, operating expenses and capital expenditures, and for other general corporate purposes. J.P. Morgan and Piper Sandler are acting as lead book-running managers for the proposed offering. RBC Capital Markets is acting as a book-running manager for the proposed offering. Cantor, Oppenheimer & Co. and H.C. Wainwright & Co. are acting as lead managers for the proposed offering.

ShowHide Related Items >><<
PLRX Pliant Therapeutics
$30.18 /

+7.525 (+33.22%)

PLRX Pliant Therapeutics
$30.18 /

+7.525 (+33.22%)

01/23/23 JPMorgan
Pliant Therapeutics price target raised to $51 from $42 at JPMorgan
01/23/23 Cantor Fitzgerald
Pliant Therapeutics price target raised to $52 from $40 at Cantor Fitzgerald
12/13/22 Stifel
Pliant Therapeutics initiated with a Buy at Stifel
12/07/22 JPMorgan
Pliant Therapeutics initiated with an Overweight at JPMorgan
PLRX Pliant Therapeutics
$30.18 /

+7.525 (+33.22%)

  • 13
    Jul
PLRX Pliant Therapeutics
$30.18 /

+7.525 (+33.22%)

Recommendations
Pliant Therapeutics price target raised to $51 from $42 at JPMorgan » 15:30
01/23/23
01/23
15:30
01/23/23
15:30
PLRX

Pliant Therapeutics

$30.27 /

+7.615 (+33.61%)

JPMorgan analyst Eric…

JPMorgan analyst Eric Joseph raised the firm's price target on Pliant Therapeutics to $51 from $42 and keeps an Overweight rating on the shares, citing raised assumptions about the odds of success of bexotegrast following the company's update on the 320mg dose INTEGRIS-IPF data. The clinical opportunity for bexotegrast in IPF is "underappreciated at current levels," the firm contends.

ShowHide Related Items >><<
PLRX Pliant Therapeutics
$30.27 /

+7.615 (+33.61%)

PLRX Pliant Therapeutics
$30.27 /

+7.615 (+33.61%)

01/23/23 Cantor Fitzgerald
Pliant Therapeutics price target raised to $52 from $40 at Cantor Fitzgerald
12/13/22 Stifel
Pliant Therapeutics initiated with a Buy at Stifel
12/07/22 JPMorgan
Pliant Therapeutics initiated with an Overweight at JPMorgan
09/01/22 Citi
Pliant Therapeutics initiated with a Buy at Citi
PLRX Pliant Therapeutics
$30.27 /

+7.615 (+33.61%)

  • 13
    Jul
PLRX Pliant Therapeutics
$30.27 /

+7.615 (+33.61%)

On The Fly
What You Missed On Wall Street This Morning » 12:01
01/23/23
01/23
12:01
01/23/23
12:01
XYL

Xylem

$100.50 /

-9.6 (-8.72%)

, AQUA

Evoqua Water

$46.50 /

+5.46 (+13.30%)

, CRM

Salesforce

$156.81 /

+5.63 (+3.72%)

, SPOT

Spotify

$100.89 /

+2.94 (+3.00%)

, BKR

Baker Hughes

$31.13 /

+0.065 (+0.21%)

, SYF

Synchrony

$34.59 /

-0.81 (-2.29%)

, WFC

Wells Fargo

$44.60 /

+0.68 (+1.55%)

, BAC

Bank of America

$34.13 /

+0.28 (+0.83%)

, PYPL

PayPal

$79.15 /

+0.06 (+0.08%)

, GS

Goldman Sachs

$344.50 /

+2.69 (+0.79%)

, WDC

Western Digital

$41.11 /

+2.68 (+6.97%)

, JPM

JPMorgan

$137.17 /

+2.1 (+1.55%)

, EADSY

Airbus

$32.29 /

+0.55 (+1.73%)

, PLRX

Pliant Therapeutics

$32.84 /

+10.185 (+44.96%)

, LCID

Lucid Group

$8.48 /

+0.67 (+8.58%)

, CPRX

Catalyst Pharmaceuticals

$14.02 /

-6.765 (-32.55%)

, TEVA

Teva

$10.34 /

-0.08 (-0.77%)

, AGEN

Agenus

$2.55 /

-0.145 (-5.38%)

, AMT

American Tower

$217.21 /

-4.26 (-1.92%)

, PEBK

Peoples Bancorp

$33.25 /

+0.62 (+1.90%)

, CZR

Caesars

$49.41 /

+1.89 (+3.98%)

, BMRC

Bank of Marin

$31.20 /

-0.37 (-1.17%)

, NWBI

Northwest Bancshares

$13.70 /

-0.105 (-0.76%)

, BOH

Bank of Hawaii

$78.07 /

-0.13 (-0.17%)

Get caught up quickly on…

ShowHide Related Items >><<
XYL Xylem
$100.50 /

-9.6 (-8.72%)

WFC Wells Fargo
$44.60 /

+0.68 (+1.55%)

WDC Western Digital
$41.11 /

+2.68 (+6.97%)

TEVA Teva
$10.34 /

-0.08 (-0.77%)

SYF Synchrony
$34.59 /

-0.81 (-2.29%)

SPOT Spotify
$100.89 /

+2.94 (+3.00%)

PYPL PayPal
$79.15 /

+0.06 (+0.08%)

PLRX Pliant Therapeutics
$32.84 /

+10.185 (+44.96%)

PEBK Peoples Bancorp
$33.25 /

+0.62 (+1.90%)

NWBI Northwest Bancshares
$13.70 /

-0.105 (-0.76%)

LCID Lucid Group
$8.48 /

+0.67 (+8.58%)

JPM JPMorgan
$137.17 /

+2.1 (+1.55%)

GS Goldman Sachs
$344.50 /

+2.69 (+0.79%)

EADSY Airbus
$32.29 /

+0.55 (+1.73%)

CZR Caesars
$49.41 /

+1.89 (+3.98%)

CRM Salesforce
$156.81 /

+5.63 (+3.72%)

CPRX Catalyst Pharmaceuticals
$14.02 /

-6.765 (-32.55%)

BKR Baker Hughes
$31.13 /

+0.065 (+0.21%)

BAC Bank of America
$34.13 /

+0.28 (+0.83%)

AQUA Evoqua Water
$46.50 /

+5.46 (+13.30%)

AMT American Tower
$217.21 /

-4.26 (-1.92%)

AGEN Agenus
$2.55 /

-0.145 (-5.38%)

XYL Xylem
$100.50 /

-9.6 (-8.72%)

01/23/23 Stifel
Xylem stock reaction to Evoqua deal 'confounding,' says Stifel
01/23/23 Raymond James
Xylem's buyout of Evoqua 'pricey,' with no accretion, says Raymond James
01/18/23 Morgan Stanley
Xylem price target raised to $115 from $105 at Morgan Stanley
01/13/23 Mizuho
Xylem price target raised to $105 from $88 at Mizuho
AQUA Evoqua Water
$46.50 /

+5.46 (+13.30%)

11/16/22 Stifel
Evoqua Water price target raised to $50 from $43 at Stifel
11/16/22 RBC Capital
Evoqua Water price target raised to $51 from $44 at RBC Capital
CRM Salesforce
$156.81 /

+5.63 (+3.72%)

01/23/23 Deutsche Bank
Salesforce price target lowered to $190 from $200 at Deutsche Bank
01/20/23 Cowen
Salesforce downgraded to Market Perform at Cowen with disruption risk elevated
01/20/23 Cowen
Salesforce downgraded to Market Perform from Outperform at Cowen
01/17/23 DA Davidson
Salesforce initiated with a Neutral at DA Davidson
SPOT Spotify
$100.89 /

+2.94 (+3.00%)

01/23/23 Piper Sandler
Spotify workforce reduction to be viewed positively, says Piper Sandler
01/17/23 Truist
Truist sees expectations for Spotify subs and active users as 'reasonable'
01/12/23 Jefferies
Spotify downgraded to Hold from Buy at Jefferies
01/05/23 UBS
Spotify price target lowered to $100 from $142 at UBS
BKR Baker Hughes
$31.13 /

+0.065 (+0.21%)

01/19/23 Benchmark
Baker Hughes initiated with a Buy at Benchmark
11/18/22 Piper Sandler
Baker Hughes price target raised to $34 from $30 at Piper Sandler
10/26/22 Wells Fargo
Wells Fargo downgrades 'show me' stock Baker Hughes to neutral
10/26/22 Wells Fargo
Baker Hughes downgraded to Equal Weight from Overweight at Wells Fargo
SYF Synchrony
$34.59 /

-0.81 (-2.29%)

01/10/23 JPMorgan
Synchrony price target lowered to $36 from $39 at JPMorgan
01/06/23 Barclays
Synchrony downgraded to Equal Weight from Overweight at Barclays
12/13/22 BofA
Synchrony downgraded to Neutral at BofA on consumer concerns
12/13/22 BofA
Discover double downgraded to Underperform at BofA on consumer concerns
WFC Wells Fargo
$44.60 /

+0.68 (+1.55%)

01/17/23 Citi
Wells Fargo price target raised to $52 from $48 at Citi
01/17/23 Piper Sandler
Wells Fargo downgraded to Neutral from Overweight at Piper Sandler
01/17/23 Jefferies
Wells Fargo downgraded to Hold from Buy at Jefferies
01/11/23 Morgan Stanley
Wells exit from correspondent 'doesn't move EPS needle,' says Morgan Stanley
BAC Bank of America
$34.13 /

+0.28 (+0.83%)

01/17/23 Citi
Bank of America price target raised to $38 from $36 at Citi
01/17/23 Piper Sandler
Bank of America downgraded to Underweight from Neutral at Piper Sandler
01/10/23 Odeon Capital
Bank of America upgraded to Buy from Hold at Odeon Capital
01/06/23 Deutsche Bank
Bank of America downgraded to Hold with $36 target at Deutsche Bank
PYPL PayPal
$79.15 /

+0.06 (+0.08%)

01/23/23 Bernstein
PayPal's 2023 earnings appear largely de-risked, says Bernstein
01/18/23 Jefferies
PayPal price target lowered to $85 from $90 at Jefferies
01/18/23 SMBC Nikko
PayPal downgraded to Underperform from Neutral at SMBC Nikko
01/09/23 KeyBanc
PayPal downgraded to Sector Weight from Overweight at KeyBanc
GS Goldman Sachs
$344.50 /

+2.69 (+0.79%)

01/18/23 Wells Fargo
Goldman Sachs price target lowered to $390 from $400 at Wells Fargo
01/10/23 Odeon Capital
Goldman Sachs upgraded to Hold from Sell at Odeon Capital
01/06/23 Morgan Stanley
Goldman Sachs price target lowered to $356 from $384 at Morgan Stanley
01/06/23 Deutsche Bank
Goldman Sachs price target lowered to $345 from $370 at Deutsche Bank
WDC Western Digital
$41.11 /

+2.68 (+6.97%)

01/23/23 Exane BNP Paribas
Western Digital upgraded to Neutral from Underperform at Exane BNP Paribas
01/06/23 Benchmark
Western Digital upgraded to Hold at Benchmark after Kioxia merger talks report
01/06/23 Benchmark
Western Digital upgraded to Hold from Sell at Benchmark
01/05/23 Deutsche Bank
Western Digital, Kioxia deal makes 'a lot of sense,' says Deutsche Bank
JPM JPMorgan
$137.17 /

+2.1 (+1.55%)

01/17/23 Citi
JPMorgan price target raised to $165 from $150 at Citi
01/17/23 Piper Sandler
JPMorgan price target raised to $157 from $150 at Piper Sandler
01/06/23 Deutsche Bank
JPMorgan downgraded to Hold with $145 target at Deutsche Bank
01/06/23 Deutsche Bank
JPMorgan downgraded to Hold from Buy at Deutsche Bank
EADSY Airbus
$32.29 /

+0.55 (+1.73%)

01/16/23 Berenberg
Airbus downgraded to Hold from Buy at Berenberg
01/11/23 JPMorgan
Airbus price target lowered to EUR 160 from EUR 170 at JPMorgan
12/07/22 Kepler Cheuvreux
Airbus downgraded to Hold from Buy at Kepler Cheuvreux
12/06/22 Jefferies
Airbus price target lowered to EUR 132 from EUR 140 at Jefferies
PLRX Pliant Therapeutics
$32.84 /

+10.185 (+44.96%)

01/23/23 Cantor Fitzgerald
Pliant Therapeutics price target raised to $52 from $40 at Cantor Fitzgerald
12/13/22 Stifel
Pliant Therapeutics initiated with a Buy at Stifel
12/07/22 JPMorgan
Pliant Therapeutics initiated with an Overweight at JPMorgan
09/01/22 Citi
Pliant Therapeutics initiated with a Buy at Citi
LCID Lucid Group
$8.48 /

+0.67 (+8.58%)

01/22/23 Citi
Lucid Group resumed with a Buy at Citi
01/12/23 Cantor Fitzgerald
Lucid's Q4 production pre-announcement 'encouraging, says Cantor Fitzgerald
01/12/23 Evercore ISI
Evercore ISI says Lucid FY/Q4 production serves as glimmer of execution progress
12/15/22 BofA
Lucid Group resumed with a Buy at BofA
CPRX Catalyst Pharmaceuticals
$14.02 /

-6.765 (-32.55%)

01/19/23 Truist
Catalyst Pharmaceuticals price target raised to $22 from $18 at Truist
12/21/22 H.C. Wainwright
Catalyst Pharmaceuticals price target raised to $24 from $18 at H.C. Wainwright
12/19/22 Piper Sandler
Catalyst Pharmaceuticals price target raised to $20 from $18 at Piper Sandler
11/10/22 Piper Sandler
Catalyst Pharmaceuticals price target raised to $18 from $16 at Piper Sandler
TEVA Teva
$10.34 /

-0.08 (-0.77%)

01/19/23 Jefferies
Teva downgraded to Hold from Buy at Jefferies
01/06/23 Northland
Alvotech named a top pick for 2023 at Northland
11/23/22 Piper Sandler
Teva price target lowered to $7 from $8 at Piper Sandler
11/14/22 JPMorgan
Teva downgraded to Underweight from Neutral at JPMorgan
AGEN Agenus
$2.55 /

-0.145 (-5.38%)

12/08/22 EF Hutton
Agenus initiated with a Buy at EF Hutton
09/27/22 SMBC Nikko
Agenus initiated with an Outperform at SMBC Nikko
03/03/22 B. Riley
Agenus price target lowered to $8 from $11 at B. Riley
03/02/22 H.C. Wainwright
Agenus price target raised to $14 from $12 at H.C. Wainwright
AMT American Tower
$217.21 /

-4.26 (-1.92%)

01/23/23 KeyBanc
American Tower downgraded to Sector Weight from Overweight at KeyBanc
01/22/23 Citi
American Tower buyout of Cellnex a possibility, says Citi
01/13/23 Truist
American Tower price target lowered to $275 from $325 at Truist
01/12/23 Deutsche Bank
American Tower upgraded to Buy from Hold at Deutsche Bank
PEBK Peoples Bancorp
$33.25 /

+0.62 (+1.90%)

CZR Caesars
$49.41 /

+1.89 (+3.98%)

01/04/23 BofA
Caesars price target lowered to $50 from $55 at BofA
12/14/22 BofA
Caesars downgraded to Neutral at BofA with growth momentum levelling out
12/14/22 BofA
Caesars downgraded to Neutral from Buy at BofA
11/28/22 JPMorgan
DraftKings downgraded to Underweight from Neutral at JPMorgan
BMRC Bank of Marin
$31.20 /

-0.37 (-1.17%)

NWBI Northwest Bancshares
$13.70 /

-0.105 (-0.76%)

09/29/22 Janney Montgomery Scott
Janney starts Northwest Bancshares with a Neutral, sees $15 fair value
09/29/22 Janney Montgomery Scott
Northwest Bancshares initiated with a Neutral at Janney Montgomery Scott
07/11/22 B. Riley
Northwest Bancshares price target lowered to $11 from $14 at B. Riley
05/06/22 Piper Sandler
Northwest Bancshares downgraded to Underweight from Neutral at Piper Sandler
BOH Bank of Hawaii
$78.07 /

-0.13 (-0.17%)

10/25/22 DA Davidson
Bank of Hawaii price target lowered to $76 from $80 at DA Davidson
07/11/22 Jefferies
Bank of Hawaii price target lowered to $79 from $87 at Jefferies
XYL Xylem
$100.50 /

-9.6 (-8.72%)

WFC Wells Fargo
$44.60 /

+0.68 (+1.55%)

WDC Western Digital
$41.11 /

+2.68 (+6.97%)

TEVA Teva
$10.34 /

-0.08 (-0.77%)

SYF Synchrony
$34.59 /

-0.81 (-2.29%)

SPOT Spotify
$100.89 /

+2.94 (+3.00%)

PYPL PayPal
$79.15 /

+0.06 (+0.08%)

PLRX Pliant Therapeutics
$32.84 /

+10.185 (+44.96%)

PEBK Peoples Bancorp
$33.25 /

+0.62 (+1.90%)

NWBI Northwest Bancshares
$13.70 /

-0.105 (-0.76%)

LCID Lucid Group
$8.48 /

+0.67 (+8.58%)

JPM JPMorgan
$137.17 /

+2.1 (+1.55%)

GS Goldman Sachs
$344.50 /

+2.69 (+0.79%)

EADSY Airbus
$32.29 /

+0.55 (+1.73%)

CZR Caesars
$49.41 /

+1.89 (+3.98%)

CRM Salesforce
$156.81 /

+5.63 (+3.72%)

CPRX Catalyst Pharmaceuticals
$14.02 /

-6.765 (-32.55%)

BOH Bank of Hawaii
$78.07 /

-0.13 (-0.17%)

BMRC Bank of Marin
$31.20 /

-0.37 (-1.17%)

BKR Baker Hughes
$31.13 /

+0.065 (+0.21%)

BAC Bank of America
$34.13 /

+0.28 (+0.83%)

AQUA Evoqua Water
$46.50 /

+5.46 (+13.30%)

AMT American Tower
$217.21 /

-4.26 (-1.92%)

AGEN Agenus
$2.55 /

-0.145 (-5.38%)

  • 13
    Jul
  • 03
    Jun
WFC Wells Fargo
$44.60 /

+0.68 (+1.55%)

WDC Western Digital
$41.11 /

+2.68 (+6.97%)

TEVA Teva
$10.34 /

-0.08 (-0.77%)

SYF Synchrony
$34.59 /

-0.81 (-2.29%)

SPOT Spotify
$100.89 /

+2.94 (+3.00%)

PYPL PayPal
$79.15 /

+0.06 (+0.08%)

LCID Lucid Group
$8.48 /

+0.67 (+8.58%)

JPM JPMorgan
$137.17 /

+2.1 (+1.55%)

GS Goldman Sachs
$344.50 /

+2.69 (+0.79%)

EADSY Airbus
$32.29 /

+0.55 (+1.73%)

CZR Caesars
$49.41 /

+1.89 (+3.98%)

CRM Salesforce
$156.81 /

+5.63 (+3.72%)

BKR Baker Hughes
$31.13 /

+0.065 (+0.21%)

BAC Bank of America
$34.13 /

+0.28 (+0.83%)

AMT American Tower
$217.21 /

-4.26 (-1.92%)

XYL Xylem
$100.50 /

-9.6 (-8.72%)

WFC Wells Fargo
$44.60 /

+0.68 (+1.55%)

WDC Western Digital
$41.11 /

+2.68 (+6.97%)

TEVA Teva
$10.34 /

-0.08 (-0.77%)

SYF Synchrony
$34.59 /

-0.81 (-2.29%)

SPOT Spotify
$100.89 /

+2.94 (+3.00%)

PYPL PayPal
$79.15 /

+0.06 (+0.08%)

PLRX Pliant Therapeutics
$32.84 /

+10.185 (+44.96%)

LCID Lucid Group
$8.48 /

+0.67 (+8.58%)

GS Goldman Sachs
$344.50 /

+2.69 (+0.79%)

EADSY Airbus
$32.29 /

+0.55 (+1.73%)

CZR Caesars
$49.41 /

+1.89 (+3.98%)

CRM Salesforce
$156.81 /

+5.63 (+3.72%)

CPRX Catalyst Pharmaceuticals
$14.02 /

-6.765 (-32.55%)

BOH Bank of Hawaii
$78.07 /

-0.13 (-0.17%)

BMRC Bank of Marin
$31.20 /

-0.37 (-1.17%)

BKR Baker Hughes
$31.13 /

+0.065 (+0.21%)

BAC Bank of America
$34.13 /

+0.28 (+0.83%)

AQUA Evoqua Water
$46.50 /

+5.46 (+13.30%)

AMT American Tower
$217.21 /

-4.26 (-1.92%)

AGEN Agenus
$2.55 /

-0.145 (-5.38%)

XYL Xylem
$100.50 /

-9.6 (-8.72%)

WFC Wells Fargo
$44.60 /

+0.68 (+1.55%)

WDC Western Digital
$41.11 /

+2.68 (+6.97%)

TEVA Teva
$10.34 /

-0.08 (-0.77%)

SYF Synchrony
$34.59 /

-0.81 (-2.29%)

SPOT Spotify
$100.89 /

+2.94 (+3.00%)

PYPL PayPal
$79.15 /

+0.06 (+0.08%)

LCID Lucid Group
$8.48 /

+0.67 (+8.58%)

JPM JPMorgan
$137.17 /

+2.1 (+1.55%)

GS Goldman Sachs
$344.50 /

+2.69 (+0.79%)

CZR Caesars
$49.41 /

+1.89 (+3.98%)

CRM Salesforce
$156.81 /

+5.63 (+3.72%)

BKR Baker Hughes
$31.13 /

+0.065 (+0.21%)

BAC Bank of America
$34.13 /

+0.28 (+0.83%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.